Karuna Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Karuna Therapeutics, Inc. has filed 460 SEC EDGAR filings since 29 Mar 2019

SEC filing history

Showing 276-300 of 460 matching filings.

Per page
25
Current page
12
4

PRIMARY DOCUMENT

Filing date
03 Mar 2021
Reporting date
01 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-239657

424B5

Filing date
02 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-239657

424B5

Filing date
01 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-253501

S-8

Filing date
25 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38958

8-K

Filing date
25 Feb 2021
Reporting date
25 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Feb 2021
Reporting date
23 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Feb 2021
Reporting date
23 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Feb 2021
Reporting date
23 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Feb 2021
Reporting date
23 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Feb 2021
Reporting date
16 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91054

SC 13G filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2021
Reporting date
10 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91054

SC 13D/A

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2021
Reporting date
09 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91054

SC 13G/A filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91054

SC 13G filing

Filing date
02 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91054

ARCH VENTURE FUND IX, L.P. -- KARUNA THERAPEUTICS -- SCHEDULE 13DA(2)

Filing date
19 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
15 Jan 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Jan 2021
Reporting date
08 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Jan 2021
Reporting date
08 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2021
Reporting date
08 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Dec 2020
Reporting date
29 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .